Cargando…

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

PURPOSE: To identify modifiable risk factors associated with prolonged clearance of methotrexate in pediatric, adolescent, and young adult (AYA) oncology patients receiving high dose methotrexate (HDMTX). DESIGN/METHOD: A single institution, retrospective chart review of patients receiving HDMTX bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mosleh, Ema, Snyder, Stacy, Wu, Ningying, Willis, Daniel N., Hayashi, Robert J., Malone, Rema
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642233/ https://www.ncbi.nlm.nih.gov/pubmed/37965460 http://dx.doi.org/10.3389/fonc.2023.1280587

Ejemplares similares

High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance
por: Chen, Aaron R, et al.
Publicado: (2020)

The effect of intravenous hydration strategy on plasma methotrexate clearance during intravenous high-dose methotrexate administration in pediatric oncology patients
por: Traivaree, Chanchai, et al.
Publicado: (2018)

Consensus Guideline for Use of Glucarpidase in Patients with High‐Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance
por: Ramsey, Laura B., et al.
Publicado: (2017)

HDMTX-based polychemotherapy including intraventricular therapy in elderly patients with primary CNS lymphoma: a single center series
por: Seidel, Sabine, et al.
Publicado: (2020)

PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2
por: De La Fuente, A., et al.
Publicado: (2022)

Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate
por: Yang, Shi-Long, et al.
Publicado: (2015)

Reduced dose folinic acid rescue after rapid high-dose methotrexate clearance is not associated with increased toxicity in a pediatric cohort
por: Niinimäki, Riitta, et al.
Publicado: (2021)

Effect of SLCO1B1 Polymorphisms on High‐Dose Methotrexate Clearance in Children and Young Adults With Leukemia and Lymphoblastic Lymphoma
por: Schulte, Rachael R., et al.
Publicado: (2020)

Cisplatin Ototoxicity: Examination of the Impact of Dosing, Infusion Times, and Schedules In Pediatric Cancer Patients
por: Camet, Miranda L., et al.
Publicado: (2021)

Eliminating Central Line Associated Bloodstream Infections in Pediatric Oncology Patients: A Quality Improvement Effort
por: Willis, Daniel N., et al.
Publicado: (2023)

Delayed High-dose Methotrexate Excretion and Influencing Factors in Osteosarcoma Patients
por: Zhang, Wei, et al.
Publicado: (2016)

Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
por: Liu, Shu-Guang, et al.
Publicado: (2017)

Efficacy of high dose methotrexate in pediatric auto-immune uveitis
por: Armbrust, Wineke, et al.
Publicado: (2014)

HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
por: Seidel, Sabine, et al.
Publicado: (2019)

Delayed clearance of triglyceride‐rich lipoproteins in young, healthy obese subjects
por: Larsen, M. A., et al.
Publicado: (2015)

Two Pediatric Osteosarcoma Cases with Delayed Methotrexate Excretion: Its Clinical Course and Management
por: Lee, Kang Min, et al.
Publicado: (2011)

Safety and efficacy of high‐dose methotrexate for osteosarcoma in adolescents compared with young adults
por: Wippel, Brittany, et al.
Publicado: (2018)

Trans Dermal Testosterone Compared to Intramuscular Testosterone for Young Males with Delayed Puberty: A PRISMA Guided Systematic Review
por: Jabari, Mosleh
Publicado: (2023)

Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Fang, Xiaowei, et al.
Publicado: (2020)

Mortality in pediatric oncology and stem cell transplant patients with bloodstream infections
por: Willis, Daniel N., et al.
Publicado: (2023)

Treatment success with two doses of methotrexate vs single dose of methotrexate in Ectopic Tubal Pregnancy
por: Khakwani, Mehnaz, et al.
Publicado: (2022)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
por: Taylor, Zachary L., et al.
Publicado: (2021)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
por: Gao, Xuan, et al.
Publicado: (2021)

Re: Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19
por: Jung, Jiwon, et al.
Publicado: (2020)

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
por: Orr, Hillary, et al.
Publicado: (2017)

Risk of higher dose methotrexate for renal impairment in patients with rheumatoid arthritis
por: Hayashi, Keigo, et al.
Publicado: (2020)

Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas
por: Ferreri, A J M, et al.
Publicado: (2004)

Renal clearance and intracellular half-life essentially determine methotrexate toxicity: A case series
por: Arakawa, Yukiyasu, et al.
Publicado: (2018)

Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
por: Meneses-Lorente, Georgina, et al.
Publicado: (2023)

Influence of genetic polymorphisms in the folate pathway on toxicity after high-dose methotrexate treatment in pediatric osteosarcoma
por: Park, Jeong A, et al.
Publicado: (2016)

Effect of the Polymorphism of Folylpolyglutamate Synthetase on Treatment of High-Dose Methotrexate in Pediatric Patients with Acute Lymphocytic Leukemia
por: Huang, Zhen, et al.
Publicado: (2016)

Feasibility of Outpatient High-Dose Methotrexate Infusions in Pediatric Patients With B-Lineage Acute Lymphoblastic Leukemia
por: Bartholomew, Joy L., et al.
Publicado: (2018)

Pediatric Collagenous Gastroenterocolitis Successfully Treated with Methotrexate
por: Beinvogl, Beate C., et al.
Publicado: (2020)

Is folate absorption impaired by high dose methotrexate?
por: Pinkerton, C. R.
Publicado: (1983)

Preventing and Managing Toxicities of High-Dose Methotrexate
por: Howard, Scott C., et al.
Publicado: (2016)

Bullous drug eruption with low dose methotrexate
por: Yuce Inel, Tuba
Publicado: (2021)

Low-Dose Methotrexate Toxicity Presenting as Pancytopenia
por: Dhillon, Gundip S, et al.
Publicado: (2022)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Isozaki, Takeo, et al.
Publicado: (2010)

Evaluation, Identification, and Management of Acute Methotrexate Toxicity in High-dose Methotrexate Administration in Hematologic Malignancies
por: Feinsilber, Doron, et al.
Publicado: (2018)

Renal Function and Plasma Methotrexate Concentrations Predict Toxicities in Adults Receiving High-Dose Methotrexate
por: Yang, Yunyun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2v1916pjkgkqg9g3qqobc141j6